IR Information

Consolidated Financial Statements

Consolidated Balance Sheets

(Millions of yen)
 
  As of March 31, 2024 As of March 31, 2025
ASSETS
Current assets
Cash and deposits 34,600 24,468
Notes and operating accounts receivable-trade, and contract assets 3,259 6,439
Electronically recorded monetary claims-operating 2,207 -
Real estate for sale 12,491 16,414
Real estate for sale in process 28,159 43,324
Costs on uncompleted construction contracts 4 1
Raw materials and supplies 28 37
Advance payments-trade 348 297
Other 1,631 1,795
Allowance for doubtful accounts △0 △0
Total current assets 82,732 92,778
Non-current assets
Property, plant and equipment
Buildings and structures 7,359 7,478
Accumulated depreciation △1,879 △2,104
Buildings and structures, net 5,480 5,374
Land 5,406 5,509
Other 458 481
Accumulated depreciation △358 △391
Other, net 100 89
Total property, plant and equipment 10,987 10,973
Intangible assets 37 34
Investments and other assets
Investment securities 405 299
Deferred tax assets 438 519
Other 690 882
Allowance for doubtful accounts △9 △8
Total investments and other assets 1,524 1,691
Total non-current assets 12,548 12,699
Total assets 95,281 105,477
LIABILITIES
Current liabilities
Notes and accounts payable-trade 2,473 2,197
Current portion of long-term loans payable 5,653 6,500
Accounts payable-other 731 494
Income taxes payable 2,069 1,989
Accrued consumption taxes 335 191
Deposits received 2,726 2,979
Provision for bonuses 318 364
Other 900 1,123
Total current liabilities 15,209 15,841
Non-current liabilities
Long-term loans payable 7,100 11,730
Long-term accounts payable-other 833 833
Net defined benefit liabilities 862 815
Long-term lease and guarantee deposited 1,897 1,989
Long-term deposits received 80 90
Provision incurred from business combination 1,253 1,253
Other 11 -
Total non-current liabilities 12,039 16,713
Total liabilities 27,249 32,555
NET ASSETS
Shareholders’ equity
Capital stock 2,774 2,774
Capital surplus 3,066 3,078
Retained earnings 63,227 68,074
Treasury stock △1,193 △1,182
Total shareholders’ equity 67,875 72,745
Accumulated other comprehensive income
Valuation difference on marketable securities 109 54
Remeasurements of defined benefit plans 47 122
Total accumulated other comprehensive income 156 176
Total net assets 68,031 72,922
Total liabilities and net assets 95,281 105,477

Consolidated Statement of Income

(Millions of yen)
  FY 2024 ended March 31, 2024 (Apr. 1, 2023 - Mar. 31, 2024) FY 2025 ended March 31, 2025 (Apr. 1, 2024 - Mar. 31, 2025)
Net sales 100,405 112,429
Cost of sales 80,231 91,785
Gross profit 20,174 20,644
Selling, general and administrative expenses
Advertising expenses 1,512 1,751
Salaries, allowances and bonuses 3,815 4,004
Provision for bonuses 291 331
Retirement benefit expenses 111 92
Provision for directors’ retirement benefits 13 -
Other 4,997 4,975
Total selling, general and administrative expenses 10,742 11,155
Operating income 9,431 9,488
Non-operating income
Interest income 0 9
Dividend income 8 10
Penalty income 18 5
Subsidy income 3 8
Other 23 21
Total non-operating income 55 55
Non-operating expenses
Interest expenses 45 78
Other 6 6
Total non-operating expenses 52 85
Ordinary income 9,434 9,459
Extraordinary losses
Loss on valuation of shares of subsidiaries and associates 34 -
Total extraordinary losses 34 -
Income before income taxes 9,400 9,459
Income taxes-current 3,178 3,069
Income taxes-deferred △231 △93
Total income taxes 2,947 2,976
Net income 6,453 6,483
Net income attributable to shareholders of parental company 6,453 6,483

Consolidated Statement of Comprehensive Income

(Millions of yen)
  FY 2024 ended March 31, 2024 (Apr. 1, 2023 - Mar. 31, 2024) FY 2025 ended March 31, 2025 (Apr. 1, 2024 - Mar. 31, 2025)
Net income 6,453 6,483
Other comprehensive income
Valuation difference on marketable securities 36 △54
Remeasurements of defined benefit plans, net of tax 59 74
Total of other comprehensive income 95 20
Comprehensive income 6,548 6,503
(Breakdown)
Comprehensive income attributable to shareholders of parental company 6,548 6,503
Comprehensive income attributable to non-controlling interests - -

Consolidated Statements of Cash Flows

(Millions of yen)
  FY 2024 ended March 31, 2024 (Apr. 1, 2023 - Mar. 31, 2024) FY 2025 ended March 31, 2025 (Apr. 1, 2024 - Mar. 31, 2025)
Cash flows from operating activities
Income before income taxes 9,400 9,459
Depreciation 360 358
Increase (decrease) in allowance for doubtful accounts △1 △0
Increase (decrease) in provision for bonuses 52 45
Increase (decrease) in provision for directors’ retirement benefits △864 -
Increase (decrease) in net defined benefit liabilities 89 62
Increase (decrease) in long-term accounts payable-other 833 -
Interest and dividend income △9 △20
Interest expenses 45 78
Decrease (increase) in notes and accounts receivable-trade, and contract assets △1,399 △972
Decrease (increase) in inventories △3,303 △19,377
Increase (decrease) in notes and accounts payable-trade 982 △241
Decrease (increase) in advances payments △162 51
Increase (decrease) in advances received △285 260
Increase (decrease) in lease and guarantee deposits received 29 92
Increase (decrease) in accrued consumption taxes 511 △95
Other, net 1,031 △223
Subtotal 7,310 △10,519
Interest and dividend income received 9 20
Interest expenses paid △44 △84
Income taxes paid △2,603 △3,296
Net cash used in operating activities 4,671 △13,880
Cash flows from investing activities
Purchase of property, plant and equipment △48 △99
Purchase of investment securities △13 △11
Decrease (increase) of time deposits △5,000 5,000
Other, net 26 17
Net cash provided by (used in) investing activities △5,036 4,906
Cash flows from financing activities
Proceeds from long-term loans payable 5,100 12,830
Repayments of long-term loans payable △5,820 △7,353
Purchase of treasury stock △0 △0
Cash dividends paid △1,568 △1,635
Net cash provided by (used in) financing activities △2,289 3,841
Net increase (decrease) in cash and cash equivalents △2,653 △5,132
Cash and cash equivalents at the beginning of the period 32,204 29,550
Cash and cash equivalents at the end of the period 29,550 24,418
TOP